Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA

66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017;... Am J Cardiovasc Drugs (2017) 17:261–264 DOI 10.1007/s40256-017-0234-3 MEE T ING R EPO R T 66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA Amitabh Prakash Published online: 12 May 2017 Springer International Publishing Switzerland 2017 The American College of Cardiology’s Annual Scientific 1 FOURIER: Evolocumab Reduces Major Session is one of the largest cardiology congresses in the Cardiovascular Events in Patients world, and the 66th Annual Scientific Session (ACC.17) with Cardiovascular Disease was held in Washington, DC, USA, from 17 to 19 March 2017, attracting 18,564 registered participants and 338 In a number of clinical trials reported over the last few media personnel. years, proprotein convertase subtilisin/kexin type 9 Founded in 1949, the American College of Cardiology (PCSK9) inhibitors (e.g., evolocumab and alirocumab) (ACC) is a non-profit medical society that strives to have demonstrated the ability to significantly reduce serum improve healthcare delivery to patients with cardiovascular low-density lipoprotein cholesterol (LDL-C) levels in patients receiving optimal-dose statin therapy. However, disease (CVD). The society comprises 50 chapters, one for each US state, and its 52,000 members are primarily car- the effect of PCSK9 inhibitors on cardiovascular outcomes remained uncertain. diovascular healthcare professionals, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA

Loading next page...
 
/lp/springer-journals/66th-annual-scientific-sessions-of-the-american-college-of-cardiology-dKoCP1eKhh

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.1007/s40256-017-0234-3
pmid
28500576
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs (2017) 17:261–264 DOI 10.1007/s40256-017-0234-3 MEE T ING R EPO R T 66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA Amitabh Prakash Published online: 12 May 2017 Springer International Publishing Switzerland 2017 The American College of Cardiology’s Annual Scientific 1 FOURIER: Evolocumab Reduces Major Session is one of the largest cardiology congresses in the Cardiovascular Events in Patients world, and the 66th Annual Scientific Session (ACC.17) with Cardiovascular Disease was held in Washington, DC, USA, from 17 to 19 March 2017, attracting 18,564 registered participants and 338 In a number of clinical trials reported over the last few media personnel. years, proprotein convertase subtilisin/kexin type 9 Founded in 1949, the American College of Cardiology (PCSK9) inhibitors (e.g., evolocumab and alirocumab) (ACC) is a non-profit medical society that strives to have demonstrated the ability to significantly reduce serum improve healthcare delivery to patients with cardiovascular low-density lipoprotein cholesterol (LDL-C) levels in patients receiving optimal-dose statin therapy. However, disease (CVD). The society comprises 50 chapters, one for each US state, and its 52,000 members are primarily car- the effect of PCSK9 inhibitors on cardiovascular outcomes remained uncertain. diovascular healthcare professionals,

Journal

American Journal of Cardiovascular DrugsSpringer Journals

Published: May 12, 2017

There are no references for this article.